Subscribe to the BioNews newsletter for free

Advanced Search

Search for

Like the Progress Educational Trust on Facebook



Public support is dependent upon health benefits

10 May 2004

By Juliet Tizzard

Director, Progress Educational Trust

Appeared in BioNews 257
Saviour siblings are back in the news. Two developments from the United States show that not only is PGD (preimplantation genetic diagnosis) and tissue typing being used successfully by more and more couples, but also that the majority of Americans support such a use of the technology.

According to a survey conducted by the Genetics and Public Policy Center, 61 per cent of those surveyed support the use of PGD to help an ailing sibling, while 33 per cent oppose it. The same survey revealed that 57 per cent of respondents oppose the use of PGD for social sex selection. Centre director, Dr Kathy Hudson, interpreted the findings as demonstrating general support for technologies which promote health rather than individual preference: 'There is strong support for using these technologies when there is a health benefit, even when that benefit is for another person.' Dr Hudson was keen to stress that most Americans do not want see a free-for-all. 'This support coexists with deep-seated worries about where all these new technologies may be taking us,' she continued. Eighty percent of those surveyed want to see regulation too control reproductive technology.

From this survey, it seems clear that health benefit - rather than the idea of choice - is the determining factor in public support for reproductive genetics. This correlates with early attitudes towardsIVF, which changed from hostility to support as more and more couples talked publicly about their inability to conceive and more and more babies were born through IVF treatment. Once the public can see a group of people who could obviously benefit from a new treatment, support for that treatment seems to grow and grow.

Does this health benefit factor work in areas such as embryonic stem cell research and therapeutic cloning, which are causing so much political strife in the United States? Public attitude surveys carried out to date are a little conflicting (depending upon who conducts them), but the idea that research could lead to new treatments for many common diseases is very important to many Americans. With scientific and political opinion building up against the Bush administration's anti-embryo research policy, it is a view which the president perhaps needs to take more seriously.

Juliet Tizzard is the Founder of BioNews and was formerly Director of the charity that publishes it, the Progress Educational Trust (PET). She is coauthor of Key Issues in Bioethics (buy this book from Amazon UK) and Designer Babies: Where Should We Draw the Line? (buy this book from Amazon UK).


Be the first to have your say.

You need to or  to add comments.

By posting a comment you agree to abide by the BioNews terms and conditions

- click here to enquire about using this story.

Published by the Progress Educational Trust


Public Conference
8 December 2017

Speakers include

Professor Azim Surani

Professor Magdalena Zernicka-Goetz

Professor Robin Lovell-Badge

Sally Cheshire

Professor Guido Pennings

Katherine Littler

Professor Allan Pacey

Dr Sue Avery

Professor Richard Anderson

Dr Elizabeth Garner

Dr Andy Greenfield

Dr Anna Smajdor

Dr Henry Malter

Vivienne Parry

Dr Helen O'Neill

Dr César Palacios-González

Philippa Taylor

Fiona Fox

Sarah Norcross

Sandy Starr


Good Fundraising Code

Become a Friend of PET HERE and give the Progress Educational Trust a regular donation